Pluristem Therapeutics Inc. is a regenerative medicine company focusing on developing placenta-based cell therapy product candidates. The company has reported successful clinical trial data in multiple indications for its patented PLX cell product candidates, and is currently conducting late-stage trials in various indications. The PLX cells are grown using the company's proprietary three-dimensional expansion technology and can be administered to patients without tissue matching. Pluristem has a strong intellectual property position, an in-house GMP-certified manufacturing and research facility, strategic relationships with research institutions, and an experienced management team.
Pluristem Therapeutics, Inc.'s ticker is PSTI
The company's shares trade on the NASDAQ stock exchange
They are based in Haifa, Israel
There are 51-200 employees working at Pluristem Therapeutics, Inc.
It is https://www.pluristem.com/
Pluristem Therapeutics, Inc. is in the Healthcare sector
Pluristem Therapeutics, Inc. is in the Biotechnology industry
The following five companies are Pluristem Therapeutics, Inc.'s industry peers: